A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives (P&T)

This study is currently recruiting participants.
Verified August 2013 by Johns Hopkins Bloomberg School of Public Health
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Carl Latkin, Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:
NCT01935440
First received: August 20, 2013
Last updated: August 30, 2013
Last verified: August 2013

August 20, 2013
August 30, 2013
February 2013
June 2017   (final data collection date for primary outcome measure)
  • change in HIV medication adherence [ Time Frame: 6 month ] [ Designated as safety issue: No ]
  • change in frequency in attending HIV medical appointments [ Time Frame: 6 month ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01935440 on ClinicalTrials.gov Archive Site
  • change in sharing injection equipment [ Time Frame: 6 month ] [ Designated as safety issue: No ]
  • change in condom use [ Time Frame: 6 month ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
Not Provided

The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators.

The primary objective of this funded research is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators to: (1) recruit their high risk social network members for voluntary HIV counseling and testing (VCT) at the research clinic, (2) promote risk reduction among social network members, and (3) promote engagement in HIV care by encouraging HIV seropositive network members to schedule and keep HIV primary care appointments. There will be four types of participants in the Full Trial: 1) Index, 2) Testing Network 3) Longitudinal Network and 4) HIV positive network participants. This longitudinal study includes baseline, 6-months, and 12-month assessments

Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
HIV
  • Behavioral: Prevention & Testing
    6 group sessions, 1 individual session, and 1 dyad session
  • Behavioral: Prevention & Testing Control
    7 group sessions
  • Active Comparator: Prevention & Testing Control
    The comparison condition is focused on basic HIV risk reduction , safety and preventing drug overdose.
    Intervention: Behavioral: Prevention & Testing Control
  • Experimental: Prevention & Testing Intervention
    The intervention condition is training on peer outreach skills which includes talking to HIV positive social network members about HIV care, medication adherence and HIV risk reduction.
    Intervention: Behavioral: Prevention & Testing
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1500
June 2017
June 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

Index

  1. 18 years old or older
  2. documentation of HIV positive status
  3. report one of following risk behaviors in past 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Testing network

  1. 18 or older
  2. provided testing coupon provided by an index participant

Longitudinal network participant-

  1. tested HIV negative at the Lighthouse via redeeming a testing coupon
  2. reported interacting with index who gave the coupon at least weekly
  3. report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Positive Networks

  1. HIV positive
  2. report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Exclusion Criteria:

Index- already enrolled in the study as a Network participant

Testing network- already enrolled in the study as a Network participant

Longitudinal network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant

Positive network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant

Both
18 Years and older
No
Contact: Carl Latkin, PhD 410-502-5368 clatkin@jhsph.edu
United States
 
NCT01935440
R01DA032217, R01DA032217
Yes
Carl Latkin, Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health
National Institute on Drug Abuse (NIDA)
Principal Investigator: Carl A Latkin, PhD Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP